Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bio-Oss Collagen + HyaDent BG is a combination regenerative therapy used for the treatment of intrabony periodontal defects in patients with periodontitis. It consists of Bio-Oss Collagen, a xenogeneic bone substitute composed of bovine-derived bone mineral and a porcine collagen matrix, and HyaDent BG, a cross-linked hyaluronic acid gel of non-animal origin. The combination functions as a bioactive scaffold; Bio-Oss Collagen provides a stable environment for osteoconduction and long-term volume maintenance, while HyaDent BG promotes wound healing, reduces inflammation, and supports the regeneration of the periodontal ligament and alveolar bone. This combination is being studied as an alternative to enamel matrix derivatives (e.g., Emdogain) for improving clinical attachment levels and reducing probing pocket depths.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bio-Oss Collagen + HyaDent BG.